20 (AIDX) Gross Margin (2025 - 2026)
20's (AIDX) quarterly Gross Margin came in at 41.71% in Q2 2026, up 1120.0% on a YoY basis from 3.42% in Q2 2025, and up 134.39% quarter-over-quarter from 17.8% in Q1 2026.
Powered by 
Analysis
20 (AIDX) Gross Margin (2025 - 2026) Analysis & Trends
20 (AIDX) has reported Gross Margin for 2 consecutive years, with 41.71% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Gross Margin rose 1120.0% year-over-year to 41.71%; the trailing twelve-month figure through Jun 2026 stood at 32.06% (changed N/A YoY), and the FY2025 full-year result was 29.56%, up 900.0% from the prior year.
- Gross Margin grew to 41.71% in Q2 2026 per AIDX's latest filing, from 17.8% in the prior quarter.
- Across five years, Gross Margin topped out at 41.71% in Q2 2026 and bottomed at 17.8% in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 47.11 Bn | 46.01 Bn | 486.15 Mn | 64.58% |
| 2 | Labcorp Holdings | 26.31 Bn | 26.16 Bn | 1.11 Bn | 29.80% |
| 3 | Quest Diagnostics | 26.02 Bn | 25.40 Bn | 1.03 Bn | 33.75% |
| 4 | Guardant Health | 21.83 Bn | 20.78 Bn | 219.03 Mn | 65.39% |
| 5 | Tempus AI | 11.08 Bn | 10.26 Bn | 274.25 Mn | 71.70% |
| 6 | Caris Life Sciences | 6.91 Bn | 6.11 Bn | 182.38 Mn | 69.16% |
| 7 | Sotera Health | 5.21 Bn | 4.85 Bn | 177.96 Mn | 55.38% |
| 8 | BillionToOne | 4.71 Bn | 4.16 Bn | 77.11 Mn | 70.45% |
| 9 | iRhythm Holdings | 3.94 Bn | 3.35 Bn | 163.21 Mn | 72.80% |
| 10 | 20 | 6.09 Mn | 1.55 Mn | 304,727.00 | 41.71% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 41.71% |
| Mar 31, 2026 | 17.80% |
| Jun 30, 2025 | 30.51% |
| Mar 31, 2025 | 29.94% |